Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Subodh Verma, MD, PhD
Tirzepatide reduces HF events in patients with HFpEF and obesity
Milton Packer, MD
CKM Syndrome Linked to Heart, Kidney, and Metabolic Diseases
Anticipated Updates on Statin Intolerance at ACC 2023
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Kevin C. Maki, PhD, FNLA, CLS
What to Know About the No Surprises Act
Charles Turck, PharmD, BCPS, BCCCP
Emily Carroll, JD, MSW
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
John Buse, MD, PhD
Anne Louise Peters, MD
Detecting & Diagnosing Diabetes in Cardiology Patients
Matthew J. Sorrentino, MD, FACC, FASH
Alan S. Brown, MD, FACC, FAHA, FNLA
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.